Saturday, October 31, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 2, 2026

Tech stocks today: Nvidia invests $4B in photonics makers, Apple announces low-cost iPhone, OpenAI strikes deal with Pentagon

View original at finance.yahoo.com
Tech stocks today: Nvidia invests $4B in photonics makers, Apple announces low-cost iPhone, OpenAI strikes deal with Pentagon Artificial intelligence leader Nvidia (NVDA) announced two new $2 billion investments into Coherent (COHR) and Lumentum (LITE), whose stocks jumped on Monday, as the AI giant looks to scale up i…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Latest iPad Airs are up to 30% faster than iPad Air with M3 processor and 2.3x faster than model with M1 chip

    80% confidence
  • Capital expenditures would increase from $15.4 billion in 2025 to at least $30 billion in 2026

    80% confidence
  • Our agreement has more guardrails than any previous agreement for classified AI deployments, including Anthropic's

    80% confidence
  • What we are witnessing is not a temporary squeeze, but a tsunami-like shock originating in the memory supply chain, with ripple effects spreading across the entire consumer electronics industry

    80% confidence
  • Data Center revenue for Q4 was record $62.3 billion, up 75% from a year ago and up 22% sequentially, driven by major platform shifts – accelerated computing and AI

    80% confidence
  • The global smartphone market, particularly Android manufacturers, faces a significant threat

    80% confidence
  • This is a simple, common-sense request that will prevent Anthropic from jeopardizing critical military operations and potentially putting our warfighters at risk

    80% confidence
  • Computing has fundamentally changed. In the age of AI, software runs on intelligence with tokens generated in real time by AI factories for every interaction and every context

    80% confidence
  • The contract language received overnight from the Department of War made virtually no progress on preventing Claude's use for mass surveillance of Americans or in fully autonomous weapons

    80% confidence
  • We retain full discretion over our safety stack, we deploy via cloud, cleared OpenAI personnel are in the loop, and we have strong contractual protections

    80% confidence
  • We cannot in good conscience accede to their request

    80% confidence
  • We don't need it, we don't want it, and will not do business with them again

    80% confidence
  • The Department of War has no interest in using AI to conduct mass surveillance of Americans (which is illegal) nor do we want to use AI to develop autonomous weapons that operate without human involvement

    80% confidence
  • I am confident in their cash flow growing

    80% confidence
  • The partnership remains strong and central between Microsoft and OpenAI

    80% confidence
  • OpenAI shares Anthropic's red lines on mass surveillance and autonomous weapons

    80% confidence
  • Anthropic would rather cut ties with government than cross two red lines: using models for mass surveillance of US citizens and using them to develop fully autonomous weapons

    80% confidence
  • For Q4, hyperscaler revenue increased and remained our largest customer category at slightly over 50% of Data Center revenue, while growth was led by the rest of our Data Center customers as revenue diversified

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com